摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ent-(+)-vindoline | 106356-49-4

中文名称
——
中文别名
——
英文名称
ent-(+)-vindoline
英文别名
(+)-vindoline;ent-vindoline;vindolin;methyl (1S,9S,10R,11S,12S,19S)-11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
ent-(+)-vindoline化学式
CAS
106356-49-4
化学式
C25H32N2O6
mdl
——
分子量
456.539
InChiKey
CXBGOBGJHGGWIE-LAVVCGCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    33
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    88.5
  • 氢给体数:
    1
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Asymmetric Total Synthesis of Vindorosine, Vindoline, and Key Vinblastine Analogues
    作者:Yoshikazu Sasaki、Daisuke Kato、Dale L. Boger
    DOI:10.1021/ja106284s
    日期:2010.9.29
    introducing essentially all the functionality found in the natural products in a single step. Implementation of the approach for the synthesis of 1 and 2 required the development of a ring expansion reaction to provide a 6-membered ring suitably functionalized for introduction of the Δ(6,7)-double bond found in the core structure of the natural products. Two unique approaches were developed that defined our
    文多林 (1) 和文多罗新 (2) 的简明不对称全合成基于独特的分子内 [4 + 2]/[3 + 2] 环加成级联 1,3,4-恶二唑,其灵感来自天然产物结构。连接亲二烯体和恶二唑的系链上的手性取代基用于控制引发 Diels-Alder 反应的面部选择性,并设置级联环加合物中剩余六个立体中心的绝对立体化学。这个关键反应引入了三个环和四个 CC 键,位于五环系统的中心,设置了所有六个立体中心,并在一个步骤中引入了天然产物中发现的基本上所有功能。实施合成 1 和 2 的方法需要发展扩环反应,以提供适当官能化的 6 元环,以引入天然产物核心结构中发现的 Δ(6,7)-双键. 开发了两种独特的方法,定义了我们使用受保护的羟甲基作为控制环加成级联立体化学过程的取代基。在这些研究过程中,制备了几种文多林类似物,其中包含目前只能通过全合成获得的深层结构变化。这些在 C6-C8 处进行关键修饰的类似物被纳
  • Synthesis of C-15 Vindoline Analogues by Palladium-Catalyzed Cross-Coupling Reactions
    作者:Peter D. Johnson、Jeong-Hun Sohn、Viresh H. Rawal
    DOI:10.1021/jo061243y
    日期:2006.9.1
    Described are general protocols for the rapid construction of various C-15-substituted analogues of vindoline using palladium-catalyzed cross-coupling reactions. The required bromo- and iodovindolines were prepared in high yield by the reaction of vindoline with N-bromosuccinimide or N-iodosuccinimide, respectively. The study not only led to the preparation of a number of structurally novel vindoline analogues but also opens the door to new strategies for the synthesis of vinblastine, vincristine, and related anticancer agents. Also described is the conversion of ent-tabersonine to ent-vindoline.
  • Total Synthesis of (−)- and <i>e</i><i>nt</i>-(+)-Vindoline
    作者:Younggi Choi、Hayato Ishikawa、Juraj Velcicky、Gregory I. Elliott、Michael M. Miller、Dale L. Boger
    DOI:10.1021/ol051975x
    日期:2005.9.1
    [reaction: see text] Two exceptionally concise total syntheses of (-)- and ent-(+)-vindoline are detailed enlisting a diastereoselective tandem [4 + 2]/[3 + 2] cycloaddition of a 1,3,4-oxadiazole. The unique reaction cascade assembles the fully functionalized pentacyclic ring system of vindoline in a single step that forms four C-C bonds and three rings while introducing all requisite functionality
    [反应:见正文]详细列举了(-)-和ent-(+)-vindoline的两种极其简洁的总合成方法,其中包括1,3,4-的非对映选择性串联[4 + 2] / [3 + 2]环加成反应恶二唑。独特的反应级联可在一个步骤中组装长满五环的长环五环系统,形成四个CC键和三个环,同时引入所有必需的功能,并在中心环内设置所有六个立体中心,包括三个连续和四个总四元中心。
  • Direct Coupling of Catharanthine and Vindoline to Provide Vinblastine:  Total Synthesis of (+)- and <i>ent</i>-(−)-Vinblastine
    作者:Hayato Ishikawa、David A. Colby、Dale L. Boger
    DOI:10.1021/ja078192m
    日期:2008.1.1
    a presumed cantharanthine amine radical cation that undergoes a subsequent oxidative fragmentation and diastereoselective coupling with vindoline, addition of the resulting reaction mixture to an Fe(III)-NaBH4/air solution leads to oxidation of the C15'-C21' double bond and reduction of the intermediate iminium ion directly providing vinblastine (43%) and leurosidine (23%), its naturally occurring C21'
    详细介绍了角黄素与文多林直接偶联以提供长春碱的关键机制和标记研究。在 Fe(III) 促进的偶联反应通过产生假定的角黄素胺自由基阳离子引发后,该阳离子经历随后的氧化断裂和与文多林的非对映选择性偶联,将所得反应混合物添加到 Fe(III)-NaBH4/空气溶液中C15'-C21' 双键的氧化和中间体亚胺离子的还原直接提供长春碱 (43%) 和亮氨酸 (23%),其天然存在的 C21' 醇异构体。仅具有天然C16'立体化学的偶联产物的产率接近或超过80%,异构C21'醇的综合产率为66%。
查看更多

同类化合物

长春立辛 长春新碱M1 脱乙酰基文多灵 罗西定碱 温都罗新 文多灵 它波宁盐酸盐 它勃宁 Ervamycine; 11-甲氧基水甘草碱 4',5'-二去氢-4'-脱氧-2',19'-二氧代-2',19'-仲长春碱 11-羟基他波宁 (-)-14,15-didehydroaspidospermidine 4-deacetyl-4-propoxylvindoline hydroxyvinamidine 4-deacetyl-4-butoxylvindoline 4-deacetyl-4-(cyclohexanecarbonyl)oxyvindoline vinamidine jerantinine A acetate N-[[(1R,9R,12R,14S,19R)-14-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6-trien-11-ylidene]amino]-4-methylbenzenesulfonamide 16-methoxy-1-methyl-6,7-didehydro-aspidospermidin-4-one (+)-20R-1,2-dehydro-Ψ-aspidospermidine methyl (1R,9R,10S,12S,19S)-12-ethenyl-8,16-diazahexacyclo[10.6.1.01,9.02,7.08,10.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate (1R,9R,12R,19R)-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6-triene-11,17-dione methyl (1R,9R,10S,12R,19S)-12-ethyl-8,16-diazahexacyclo[10.6.1.01,9.02,7.08,10.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate 3-Oxo-11-methoxytabersonine Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12beta,19alpha)- melodinine P N-methyltabersonine 14,15-didehydro-16-hydroxy-<3H>indole ent-N(1)-methyl-14,15-didehydroaspidospermidine vindoline hydrochloride Mbid (3aS,5R,10bR,12bS)-5-Chloro-3a-ethyl-12-oxo-2,3,3a,4,5,11,12,12b-octahydro-1H-6,12a-diaza-indeno[7,1-cd]fluorene-5-carboxylic acid methyl ester (3aS,5R,10bR,12R,12bS)-5-Chloro-12-cyano-3a-ethyl-2,3,3a,4,5,11,12,12b-octahydro-1H-6,12a-diaza-indeno[7,1-cd]fluorene-5-carboxylic acid methyl ester (3aS,5aR,10bR,12bR)-6-Ethyl-2,3,3a,5a,6,12b-hexahydro-1H,5H-6,12a-diaza-indeno[7,1-cd]fluorene-4,12-dione jerantinine A jerantinine C 10-O-methyljerantinine A baloxine 2βH,3αH-tubersonine methyl 15-bromo-2,3,6,7-tetrahydro-(5α,12β,19α)-aspidospermidine-3-carboxylate methyl 15-bromo-6,7-didehydro-(2β,5α,12β,19α)-aspidospermidine-3α-carboxylate 2,3-didehydro-20,21-dinor-aspidospermidine-3-carboxylic acid methyl ester methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(1R,3S,14R)-18-ethyl-3-methoxycarbonyl-14-[[(2S)-2-methoxycarbonylpyrrolidin-1-yl]methyl]-5,16-diazatetracyclo[14.3.1.04,12.06,11]icosa-4(12),6,8,10,18-pentaen-3-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate 20-deethyl-17-ethoxy-1-(p-tolylsulfonyl)-2,16,17,20-tetradehydroaspidospermidine 3α-acetonyl-tabersonine 20-desethyl-17-formyl-5-oxo-16,17-dehydroaspidospermidine Alkaloid XC-99 16-Chloro-1-dehydrovincadifformine Methyl 11-acetyloxy-12-ethyl-4-[(Z)-1-(16-ethyl-16-hydroxy-3,13-diazatetracyclo[11.2.2.02,10.04,9]heptadeca-2(10),4,6,8-tetraen-15-yl)-3-methoxy-3-oxoprop-1-en-2-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate